ACOR - Acorda Therapeutics beats by $0.31 beats on revenue October, 31 2018 06:01 AM Acorda Therapeutics Inc. Acorda Therapeutics (NASDAQ:ACOR): Q3 Non-GAAP EPS of $0.17 beats by $0.31; GAAP EPS of -$0.29 beats by $0.01. More news on: Acorda Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...